MYLOTARG subst sèche 5 mg flac

7680668790012 CH-66879 L01FX02 07.16.1.
MYLOTARG subst sèche 5 mg flac
MYLOTARG subst sèche 5 mg flac
MYLOTARG subst sèche 5 mg flac
1 / 3
google

Details

Product number
6687901
CPT
-
Packaging group
1
Unit
Durchstechflasche(n)
Composition
gemtuzumabum ozogamicinum 5 mg, saccharum, dextranum 40, natrii chloridum, natrii dihydrogenophosphas monohydricus, dinatrii phosphas, pro vitro corresp. natrium 12.54 mg.

Articles (1)

Mylotarg 5 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
06/07/2023
Professional SmPC
Français
06/07/2023
Professional SmPC
Italien
06/07/2023

Detailed composition

Substance Quantity Type Category
(N/A)
5.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
12.54 MG Substance HBESI

Authorization holder

Pfizer AG

8052 Zürich

Authorization information

Swissmedic authorization number
66879
Drug name
Mylotarg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Galenic form
PULPI
ATC Code
L01FX02
Authorization status
Z
Dispensation category
A
First authorization
05/12/2019
Authorization expiration date
31/12/9999
IT number
07.16.1.
Domain
Human medicine
Field of application
akute myeloische Leukämie

Packaging details

Description (FR)
MYLOTARG subst sèche 5 mg flac
Description (DE)
MYLOTARG Trockensub 5 mg Durchstf
Market launch
05/12/2019
Narcotic (BTM)
No